FESTUCCIA, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 1.711
EU - Europa 1.151
AS - Asia 351
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 3.222
Nazione #
US - Stati Uniti d'America 1.707
IE - Irlanda 424
CN - Cina 241
DE - Germania 205
SE - Svezia 146
IT - Italia 139
TR - Turchia 82
UA - Ucraina 81
GB - Regno Unito 61
BE - Belgio 28
FR - Francia 28
FI - Finlandia 17
CZ - Repubblica Ceca 13
VN - Vietnam 13
IN - India 8
EU - Europa 5
SG - Singapore 4
CA - Canada 3
AU - Australia 2
NL - Olanda 2
NZ - Nuova Zelanda 2
RU - Federazione Russa 2
AL - Albania 1
AT - Austria 1
BN - Brunei Darussalam 1
IL - Israele 1
JP - Giappone 1
LU - Lussemburgo 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
Totale 3.222
Città #
Chandler 453
Dublin 420
Jacksonville 318
Ann Arbor 103
New York 77
Ashburn 68
Izmir 59
L'aquila 58
Wilmington 57
Nanjing 56
Bremen 53
Lawrence 53
Princeton 53
Beijing 42
Grafing 38
Woodbridge 38
Boardman 37
Brussels 28
San Mateo 27
Shenyang 22
Nanchang 21
Seattle 19
Munich 16
Falls Church 15
Tianjin 14
Kunming 13
Brno 12
Dong Ket 12
Milan 12
Berlin 11
Dearborn 10
Mountain View 10
Des Moines 9
Los Angeles 9
Rome 9
Changsha 8
Hebei 8
Jinan 8
Norwalk 8
Washington 7
Hanover 6
Jiaxing 6
L’Aquila 6
Napoli 6
Pune 5
Shanghai 5
Verona 5
Zhengzhou 5
Ningbo 4
Taizhou 4
Cedar Knolls 3
Controguerra 3
Frankfurt am Main 3
Fremont 3
Guangzhou 3
Houston 3
Phoenix 3
Tappahannock 3
Fairfield 2
Garland 2
Menlo Park 2
Piombino Dese 2
Redwood City 2
Termoli 2
Toronto 2
Amsterdam 1
Ascoli Piceno 1
Auburn Hills 1
Auckland 1
Bandar Seri Begawan 1
Beauharnois 1
Bellante 1
Bracknell 1
Carlentini 1
Casoria 1
Changchun 1
Detroit 1
Düsseldorf 1
Edinburgh 1
Fuzhou 1
Hangzhou 1
Hanoi 1
Hefei 1
Helsinki 1
Irkutsk 1
Lanzhou 1
Lappeenranta 1
Lodi 1
Logan 1
Luxembourg 1
Manchester 1
Newark 1
Orange 1
Oslo 1
Panama City 1
Pavia 1
San Diego 1
San Francisco 1
Shenzhen 1
Shreveport 1
Totale 2.416
Nome #
From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis 107
C-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines 104
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 102
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 93
Prevention of chemotherapy-induced gonadotoxicity in the mouse model: protective effects of natural bioactive compounds 93
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 91
PPARγ-dependent effects of conjugated linoleic acid on a human glioblastoma cell line (ADF) 88
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 87
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 85
Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention 78
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study 76
Editorial: Antitarget Therapies: New Frontiers in the Treatment of Cancer 76
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 76
EPHRIN A2 ANTAGONISM REDUCES SURVIVAL OF PROSTATE CANCR CELLS AFTER CHEMOTHERAPIC TREATMENTS AND ANGIOGENESIS IN PROSTATE CANCER CELLS BOTH IN VITRO AND IN VIVO 75
Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pARser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy 74
Tebuconazole and Econazole Act Synergistically in Mediating Mitochondrial Stress, Energy Imbalance, and Sequential Activation of Autophagy and Apoptosis in Mouse Sertoli TM4 Cells: Possible Role of AMPK/ULK1 Axis 74
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis 74
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer 73
Suppression of SRC signaling is effective in reducing synergy between glioblastoma and stromal cells 71
Immunolocalization of Advanced Glycation End Products, Mitogen Activated Protein Kinases, and Transforming Growth Factor-β/Smads in Pelvic Organ Prolapse 70
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 66
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 64
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 63
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 63
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and surviving in prostate cancer models 61
Editorial: New Drug Targets for Treatment of Recurrent/Metastatic Prostate Cancer 59
The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models 58
Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth 58
Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models. 56
Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models 56
New therapeutic approaches for the treatmemt of glioblastoma 56
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 56
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models 56
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 56
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer 55
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 55
Fertility preservation in cancer patients: attenuation of chemotherapy-induced ovarian damage by oral administration of phytochemical carotenoids in an animal model. 54
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 53
Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps? 51
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 47
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling 46
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 46
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma 44
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma 40
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 39
Lactobacillus sakei pro-bio65 reduces tnf-α expression and upregulates gsh content and antioxidant enzymatic activities in human conjunctival cells 39
The importance of tumor stem cells in glioblastoma resistance to therapy 37
Synergistic Activity of Ketoconazole and Miconazole with Prochloraz in Inducing Oxidative Stress, GSH Depletion, Mitochondrial Dysfunction, and Apoptosis in Mouse Sertoli TM4 Cells 37
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma 36
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 34
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 32
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 32
Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model 26
Targeting ddx3x helicase activity with ba103 shows promising therapeutic effects in preclinical glioblastoma models 25
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties 13
Totale 3.336
Categoria #
all - tutte 12.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019101 0 0 0 0 0 0 0 0 0 0 0 101
2019/2020403 69 4 39 9 3 56 79 11 47 32 7 47
2020/2021426 12 45 4 52 44 17 57 6 65 23 71 30
2021/2022399 22 3 68 25 12 54 16 14 35 37 25 88
2022/20231.236 73 93 18 173 105 120 0 92 502 11 30 19
2023/2024351 42 13 20 13 26 135 10 12 1 9 17 53
Totale 3.336